BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30635211)

  • 41. Analysis of survival in very early hepatocellular carcinoma after resection.
    Lee JI; Lee JW; Kim YS; Choi YA; Jeon YS; Cho SG
    J Clin Gastroenterol; 2011 Apr; 45(4):366-71. PubMed ID: 20962671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer.
    Matsuda M; Fujii H; Kono H; Matsumoto Y
    J Hepatobiliary Pancreat Surg; 2001; 8(4):353-9. PubMed ID: 11521181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
    Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
    Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study.
    Yang B; Xi X; Yu H; Jiang H; Liang Z; Smayi A; Wu B; Yang Y
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2030. PubMed ID: 38488487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population.
    Schwarz RE; Smith DD
    Am J Surg; 2008 Jun; 195(6):829-36. PubMed ID: 18436176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Liu Z; Zhou Y; Zhang P; Qin H
    Surg Laparosc Endosc Percutan Tech; 2010 Jun; 20(3):130-40. PubMed ID: 20551807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database.
    Berger NG; Tanious MN; Hammad AY; Miura JT; Mogal H; Clarke CN; Christians KK; Tsai S; Gamblin TC
    J Surg Oncol; 2017 Sep; 116(3):307-312. PubMed ID: 28464313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort Study.
    Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
    Int J Surg; 2017 Oct; 46():178-185. PubMed ID: 28890407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of hepatic resection for hepatocellular carcinoma: the role of the surgeon in achieving R0 resection--a retrospective cohort study.
    Huan-Wei C; Shan L; Wan-Yee L; Feng-Jie W; Fei-Wen D; Chun-Hung LE; Zuo-Jun Z
    Int J Surg; 2015 Jan; 13():297-301. PubMed ID: 25541435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma.
    Parisi A; Desiderio J; Trastulli S; Castellani E; Pasquale R; Cirocchi R; Boselli C; Noya G
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):270-7. PubMed ID: 23742772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of anatomic resection for early and advanced hepatocellular carcinoma.
    Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
    Langenbecks Arch Surg; 2012 Jan; 397(1):85-92. PubMed ID: 21904926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
    Chirica M; Scatton O; Massault PP; Aloia T; Randone B; Dousset B; Legmann P; Soubrane O
    Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances of radiofrequency ablation for early hepatocellular carcinoma.
    Izumi N
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():115-22. PubMed ID: 21199522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study.
    Qiu J; Lu W; Yu N; Yang G; Li Y; Huang Z; Li J; Li K; Xu H; Chen S; Zeng X; Liu H
    Oncotarget; 2017 Jan; 8(3):4218-4227. PubMed ID: 27965468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.